ICON Financial Ratios
NASDAQ: ICLRHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ICON ratio analysis
ICON earned a net margin of 2.8% in FY 2025, down from 9.0% a year earlier. Gross margin was 26.4% compared with a median of 29.2% over the prior 9 years. Return on equity reached 2.5%, meaning ICON generated 0.02 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.31 versus 0.36 the year before, and the current ratio was 1.10. At the end of FY 2025, ICLR traded at 65.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 16.2 to 137.6, with a median of 28.2. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
ICON financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 65.06 | 23.96 | 42.25 | 31.69 | 137.64 | 31.70 | 24.76 | 20.99 | 21.86 | 16.17 |
| Price / sales | 1.79 | 2.15 | 2.89 | 2.05 | 3.79 | 3.68 | 3.23 | 2.58 | 3.45 | 2.49 |
| Price / book | 1.61 | 1.86 | 2.52 | 1.86 | 2.58 | 5.57 | 5.60 | 4.94 | 5.10 | 4.40 |
| Gross margin | 26.4% | 28.6% | 29.0% | 28.6% | 27.5% | 29.2% | 29.6% | 30.0% | 41.6% | 42.3% |
| Operating margin | 5.4% | 12.6% | 11.2% | 10.3% | 6.9% | 14.0% | 15.4% | 14.4% | 19.2% | 18.7% |
| Net margin | 2.8% | 9.0% | 6.9% | 6.5% | 2.8% | 11.9% | 13.3% | 12.4% | 16.0% | 15.7% |
| Free cash flow margin | 10.4% | 13.7% | 12.7% | 5.4% | 13.4% | 18.8% | 13.3% | 8.5% | 19.2% | 13.0% |
| Return on equity (ROE) | 2.5% | 7.8% | 6.0% | 5.9% | 1.9% | 18.0% | 23.1% | 23.8% | 23.6% | 27.7% |
| Return on assets (ROA) | 1.4% | 4.4% | 3.3% | 2.9% | 0.9% | 9.7% | 12.9% | 13.7% | 13.1% | 14.4% |
| Debt / equity | 0.31 | 0.36 | 0.40 | 0.54 | 0.67 | 0.19 | — | — | — | — |
| Current ratio | 1.10 | 1.24 | 1.20 | 1.20 | 1.19 | 1.87 | 1.44 | 2.18 | 1.95 | 1.94 |
| Revenue growth | 0.8% | 1.7% | 4.1% | 41.2% | 95.9% | -0.3% | 8.1% | 47.6% | 5.5% | 5.8% |
| EPS growth | -67.4% | 32.8% | 9.3% | 172.4% | -63.4% | -9.4% | 15.3% | 14.8% | 10.3% | 17.1% |